GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (STU:1FG) » Definitions » Future 3-5Y EPS without NRI Growth Rate

FibroGen (STU:1FG) Future 3-5Y EPS without NRI Growth Rate : 48.35 (As of Sep. 22, 2024)


View and export this data going back to 2015. Start your Free Trial

What is FibroGen Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, FibroGen's Future 3-5Y EPS without NRI Growth Rate is 48.35.


Competitive Comparison of FibroGen's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, FibroGen's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FibroGen's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroGen's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where FibroGen's Future 3-5Y EPS without NRI Growth Rate falls into.



FibroGen  (STU:1FG) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


FibroGen Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of FibroGen's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroGen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (STU:1FG) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Traded in Other Exchanges
Address
409 Illinois Street, San Francisco, CA, USA, 94158
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

FibroGen Headlines

No Headlines